| Literature DB >> 33833485 |
Toshihiro Nishizawa1, Shuntaro Yoshida2, Akira Toyoshima3, Tomoharu Yamada4, Yoshiki Sakaguchi5, Taiga Irako6, Hirotoshi Ebinuma7, Takanori Kanai8, Kazuhiko Koike5, Osamu Toyoshima2.
Abstract
BACKGROUND: Hyperplastic polyps are considered non-neoplastic, whereas sessile serrated lesions (SSLs) are precursors of cancer via the ''serrated neoplastic pathway''. The clinical features of SSLs are tumor size (> 5 mm), location in the proximal colon, coverage with abundant mucus called the ''mucus cap'', indistinct borders, and a cloud-like surface. The features in magnifying narrow-band imaging are varicose microvascular vessels and expanded crypt openings. However, accurate diagnosis is often difficult. AIM: To develop a diagnostic score system for SSLs.Entities:
Keywords: Endoscopic features; Hyperplastic polyp; Indistinct borders; Mucus cap; Sessile serrated lesion; Size
Year: 2021 PMID: 33833485 PMCID: PMC8015299 DOI: 10.3748/wjg.v27.i13.1321
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
Figure 1Endoscopic findings regarding sessile serrated lesions. A: ‘‘Mucus cap’’ was defined as coverage with abundant mucus; and B: Indistinct borders were defined as vague demarcations of the lesion border.
Figure 2Flowchart of polyp enrollment.
Polyp characteristics
|
|
|
| Size | |
| Diminutive (≤ 5 mm) | 114 |
| Small (6-9 mm) | 82 |
| Large (≥ 10 mm) | 36 |
| Shape (Paris classification) | |
| Is | 4 |
| IIa | 226 |
| IIb | 1 |
| IIc | 1 |
| Location | |
| Cecum | 33 |
| Ascending colon | 61 |
| Transvers colon | 71 |
| Descending colon | 12 |
| Sigmoid colon | 42 |
| Rectum | 13 |
| Pathology | |
| Sessile serrated lesion | 72 |
| Hyperplastic polyp | 130 |
| Traditional serrated adenoma | 1 |
| Adenoma | 7 |
| Normal mucosa | 20 |
| Others | 2 |
Univariate and multivariate analyses on the diagnosis of sessile serrated lesion
|
|
|
| ||||
|
|
|
|
|
|
|
|
| Location (proximal colon) | 1.094 | 0.374-1.813 | 0.003 | 0.197 | -0.685-1.078 | 0.662 |
| Size (> 5mm) | 2.050 | 1.369-2.731 | < 0.001 | 0.904 | 0.074-1.733 | 0.033 |
| Mucus cap | 2.548 | 1.657-3.440 | < 0.001 | 1.520 | 0.448-2.592 | 0.005 |
| Indistinct borders | 2.067 | 1.371-2.764 | < 0.001 | 0.926 | 0.075-1.778 | 0.033 |
| Varicose microvascular vessel | 0.668 | 0.088-1.248 | 0.024 | -0.133 | -0.869-0.602 | 0.723 |
| Cloud-like surface | 1.640 | 1.015-2.264 | < 0.001 | 0.708 | -0.022-1.437 | 0.057 |
| Expanded crypts opening | 0.367 | -0.202-0.936 | 0.206 | -0.497 | -1.198-0.203 | 0.164 |
Figure 3Receiver-operating characteristic curve for predicting sessile serrated lesions. A: Receiver-operating characteristic (ROC) curve for predicting sessile serrated lesion (SSL) based on the endoscopic SSL diagnosis score: The area under the curve (AUC) was 0.806. The optimal cutoff value was 3, for which the endoscopic SSL diagnosis score predicted pathological SSLs with 75% sensitivity and 80% specificity; B: ROC curve for predicting SSL based on polyp size: AUC was 0.801. Size ≥ 6 mm predicted pathological SSLs with 82% sensitivity, and 63% specificity; C: ROC curve for predicting SSL based on mucus cap: AUC was 0.727. The presence of mucus cap predicted pathological SSLs with 92% sensitivity, and 54% specificity; and D: ROC curve for predicting SSL based on indistinct borders: AUC was 0.723. The presence of indistinct borders predicted pathological SSLs with 83% sensitivity, and 61% specificity.
Figure 4Sessile serrated lesion diagnosis rates based on the endoscopic sessile serrated lesion diagnosis score. a P < 0.05 compared to an endoscopic Sessile serrated lesion diagnosis score of 0; bP < 0.001 compared to an endoscopic sessile serrated lesion diagnosis score of 0, 1, or 2. SSL: Sessile serrated lesion.